X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.
John Castellani

John Castellani John J. Castellani is past President and Chief Executive Officer of the Pharmaceutical Research and Manufacturers of America (PhRMA). He is a passionate advocate for a strong, innovative and growing American biopharmaceutical research industry that plays a critical role in helping to improve the health of every American and patients the world-over. Mr. Castellani is also the former President and CEO of Business Roundtable, an association of chief executive officers of leading U.S. corporations with a combined workforce of nearly 12 million employees and $6 trillion in annual revenues.

Recent Posts

Helping patients in times of need

By John Castellani  |    September 29, 2015
When Hurricane Katrina hit, the lack of communication between public health officials and the private sector, which controls most of the biopharmaceutical supply chain system slowed.  This gap...   Read More

Secretary Clinton’s proposal would turn back the clock on medical innovation

By John Castellani  |    September 22, 2015
The sweeping proposals outlined in Secretary Clinton’s plan to regulate prescription drug prices would restrict patients’ access to medicines, result in fewer new treatments for patients, cost...   Read More

New Chart Pack: Big Strides in Fight Against Cancer

By John Castellani  |    May 28, 2015
In December 2009, Matt Ellefson received news from his doctor that no one ever wants to receive: a diagnosis of advanced non-small cell lung cancer. He faced a five-year survival rate of less than...   Read More

PhRMA Member Companies Invested $51.2 Billion in R&D in 2014

By John Castellani  |    April 20, 2015
Earlier today, the Pharmaceutical Research and Manufacturers of America (PhRMA) announced that its member companies have invested more than $600 billion in the search for new treatments and cures...   Read More

PhRMA’s John Castellani Gives Attendees a 2015 Leukemia Ball Sneak Peek

By John Castellani  |    March 2, 2015
This piece first appeared on WashingtonExec on February 25, 2015. On Saturday, March 28, the Leukemia & Lymphoma Society (LLS) will host its 2015 Leukemia Ball. This annual black-tie event starts at...   Read More

Our Commitment to Advancing Patient-Centered Payment Models

By John Castellani  |    January 26, 2015
PhRMA supports Secretary Burwell’s goal of advancing affordable, high quality and patient centered health care, and today’s announcement represents an important step forward.   Read More

How We’re Curing The Incurable

By John Castellani  |    December 18, 2014
This post first appeared on the Morning Consult.  In 1989, while the world watched the Berlin Wall fall and history opened a new chapter, researchers in government and private labs half a world away...   Read More

Working Together to Stop Ebola in its Tracks

By John Castellani  |    November 13, 2014
The fantastic news came yesterday that Dr. Craig Spencer, the last patient in the U.S. with Ebola, has been cured. While this development certainly inspires hope, there is still much to be done in...   Read More

New Report Shows Past Drug Failures Aid in the Fight Against Cancer

By John Castellani  |    October 8, 2014
This week PhRMA released a new report, “Researching Cancer Medicines: Setbacks and Stepping Stones,” which examines the investigational cancer medicines that did not succeed in clinical trials and...   Read More

Why Are Cancer Medicines Expensive?

By John Castellani  |    October 6, 2014
This post first appeared on the Morning Consult.  Prescription medicines account for just nine cents of every dollar spent on health care in the U.S., and cancer medicines represent just one percent...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates